SCHEDULE 13G
Statement of Beneficial Ownership
Annovis Bio, Inc. Filed Acc 0000919574-26-005355
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Highbridge Capital Management, LLC | 2,775,578 | 6.1% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-10-15 SCHEDULE 13G/A · Empery Asset Management, LP 4.99%
- 2026-08-14 SCHEDULE 13G · Highbridge Capital Management, LLC 6.1%
- 2026-07-29 SCHEDULE 13G · Empery Asset Management, LP 5.64%
- 2025-05-12 SCHEDULE 13G/A · CVI Investments, Inc. 4.9%
- 2025-02-10 SCHEDULE 13G · CVI Investments, Inc. 5.1%
- 2023-11-28 SC 13G/A · AIGH Investment Partners, L.L.C. 34%
- 2023-11-08 SC 13G · AIGH Investment Partners, L.L.C. 24%
- 2021-01-28 SC 13G/A · AIGH Investment Partners, L.L.C. 51%
- 2020-07-21 SC 13G · AIGH Investment Partners, L.L.C. 51%
- 2020-07-10 SC 13G/A · AIGH Investment Partners, L.L.C. 54%
- 2020-04-20 SC 13D · Maria L. Maccecchini 19.4%
- 2020-01-30 SC 13G · AIGH Investment Partners, L.L.C. 54%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…